Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/1999
09/01/1999EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist
09/01/1999EP0938321A1 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
09/01/1999EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor
09/01/1999EP0938305A2 Method of alleviating pain by means of combining tramadol with an nmda antagonist
09/01/1999EP0938303A1 Antioxidant-induced apoptosis in vascular smooth muscle cells
09/01/1999EP0938296A1 Method of treating alopecia
09/01/1999EP0723455A4 Methods of inhibiting phagocytosis
09/01/1999CN1227603A TIE-2 receptor ligands (TIE ligand-3; TIE ligand-4) and their uses
09/01/1999CN1227496A Screening method for compounds useful in the regulation of body weight
09/01/1999CN1227494A Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cell
09/01/1999CN1227493A The use of heparin or heparan sulfate in combination with chitosan for prevention or treatment of infections caused by herpes virus
08/1999
08/31/1999US5945545 Substitiuted amidinobenzene compounds; anticoagulants
08/31/1999US5945510 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
08/31/1999US5945505 Human phospholemman-like protein
08/31/1999US5945456 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
08/31/1999US5945452 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
08/31/1999US5945441 Administering to promote hair germination
08/31/1999US5945411 Chemoprevention of metachronous adenomatous colorectal polyps
08/31/1999US5945330 Polynucleotide
08/31/1999US5945315 Isolating compound from culture of gsv224 nostoc species; antiproliferative agent for drug resistant cells
08/31/1999US5945308 Polynucleotide
08/31/1999US5945272 Autoclavable mixture of subphysiological concentrations of potassium, magnesium, sodium, calcium and chloride ions; water soluble oncotic agents; carboxylic acids or salts; and blood clotting factors; free of biological buffers
08/31/1999US5945124 Bactericide
08/31/1999US5945121 Liposome eye drops
08/31/1999US5945106 A concentrated extract of reduced nordihydroguairetic acid containing larrea tridentate plant material, and ascorbic acid, a corticosteroid, a nonsteroid anti-inflammatory, an antiinflammatory fatty acid, p-antagonsist, and an anesthetic
08/31/1999US5944021 Therapeutic use of a carbonic anhydrase enzyme inhibitor for the treatment of brain edema
08/31/1999CA2118030C Drug for increasing the level of testosterone in the body
08/31/1999CA2007334C Anti-ulcer composition
08/26/1999WO1999042839A2 Treating cancer
08/26/1999WO1999042837A1 Treating cancer
08/26/1999WO1999042836A1 Treating cancer
08/26/1999WO1999042835A1 Treating cancer
08/26/1999WO1999042834A2 Treating cancer
08/26/1999WO1999042828A2 Treating cancer
08/26/1999WO1999042821A2 Treating cancer
08/26/1999WO1999042606A1 Methods of screening agents for activity using teleosts
08/26/1999WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR
08/26/1999WO1999042596A2 Phosphodiesterase 10
08/26/1999WO1999042593A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
08/26/1999WO1999042579A2 Caf1-related protein
08/26/1999WO1999042578A2 Modulation of cell proliferation, methods and reagents
08/26/1999WO1999042562A1 NOVEL pgsA
08/26/1999WO1999042481A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF
08/26/1999WO1999042136A1 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions
08/26/1999WO1999042133A1 Inhibitors of complement activation
08/26/1999WO1999042128A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
08/26/1999WO1999042121A1 Modified heat shock protein-antigenic peptide complex
08/26/1999WO1999042116A1 Novel disulfides and thiol compounds
08/26/1999WO1999042111A1 High-energy cyclodextrin complexes
08/26/1999WO1999042101A1 Dietary control of arachidonic acid metabolism
08/26/1999WO1999042099A1 Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof
08/26/1999WO1999042098A1 Small molecules that increase the conversion of food to body weight gain
08/26/1999WO1999042097A1 Small molecules that elicit a polarized th1 response and for modulation of cellular immunity
08/26/1999WO1999042096A1 Composition comprising theanine
08/26/1999WO1999042095A1 Pharmaceutical combinations containing tramadol
08/26/1999WO1999042090A2 Treating cancer
08/26/1999WO1999042088A2 Method for the treatment of diseases or disorders of the inner ear
08/26/1999WO1999042083A1 Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
08/26/1999WO1999033989A3 Rantes mutants and therapeutic applications thereof
08/26/1999WO1999031136A3 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells
08/26/1999WO1999031060A3 Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants
08/26/1999WO1999030697A3 Combination effective for the treatment of impotence
08/26/1999WO1999028342A3 Low-voltage activated calcium channel compositions and methods
08/26/1999WO1999026609A3 Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia
08/26/1999WO1999004265A3 Cancer associated nucleic acids and polypeptides
08/26/1999DE19909251A1 Agents for treating human diseases, particularly cancer, modulate interaction of beta-catenin with transcription factors or tumor suppressor gene products
08/26/1999DE19907493A1 Recombinant nucleic acid encoding modified forms of peptides involved in neurodegenerative diseases, useful for identifying potential therapeutic agents
08/26/1999DE19824653A1 Use of compounds concentrating in necrotic tissue as drug depots, e.g. for radiation therapy, pharmacotherapy, restenosis prevention and diagnosis
08/26/1999DE19811326C1 Preparation of medicaments for the treatment of tumor diseases and for immuno-suppression
08/26/1999DE19807535A1 Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying
08/26/1999CA2357015A1 Agents for treating human illnesses based on .beta.-catenin, and the production and use thereof
08/26/1999CA2321961A1 Novel disulfides and thiol compounds
08/26/1999CA2321814A1 Small molecules that increase the conversion of food to body weight gain
08/26/1999CA2321482A1 Treating cancer
08/26/1999CA2321481A1 Treating cancer
08/26/1999CA2321480A1 Treating cancer
08/26/1999CA2321479A1 Treating cancer
08/26/1999CA2321467A1 Treating cancer
08/26/1999CA2321458A1 Treating cancer
08/26/1999CA2321438A1 Treating cancer
08/26/1999CA2321224A1 Phosphodiesterase 10
08/26/1999CA2321222A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
08/26/1999CA2321140A1 Inhibitors of complement activation
08/26/1999CA2321101A1 Modified heat shock protein-antigenic peptide complex
08/26/1999CA2320808A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
08/26/1999CA2320772A1 High-energy cyclodextrin complexes
08/26/1999CA2320632A1 Caf1-related protein
08/26/1999CA2318811A1 Modulation of cell proliferation, methods and reagents
08/26/1999CA2309943A1 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions
08/25/1999EP0937777A2 GABA receptors and their uses
08/25/1999EP0937464A2 Combined pharmaceutical preparation containing inhibitors of the sodium hydrogen exchange and a medicament for the treatment of cardiovascular diseases
08/25/1999EP0937460A2 Use of an antidiarrheal for the manufacture of a medicament for the treatment of inflammatory conditions
08/25/1999EP0937146A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
08/25/1999EP0937144A1 Human eosinophil-derived basic protein
08/25/1999EP0937140A2 Recognition molecules interacting specifically with the active site or cleft of a target molecule
08/25/1999EP0937101A1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them
08/25/1999EP0936924A2 Pharmaceutical composition containing a 5ht 2c? antagonist and a d 2? antagonist
08/25/1999EP0936918A1 Combination therapy for treatment of arthritic diseases
08/25/1999EP0936915A1 Chelating agents and their metal chelates for treating free radicals induced conditions
08/25/1999EP0661967B1 Combined virustatic antimediator (covam) treatment of common colds
1 ... 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 ... 1151